The company’s main focus is to commercialize its unique and propriatary product series called TailorDose®. TailorDose® is a product line that meets the need for personalized cancer medicine relating to drugs that are difficult to dose, such as cyclophosphamide (CPA). The first product in this series is TailorDose®-CPA and is intended for cancer care in conditions such as breast cancer. There is a great medical need for personalized dosing of CPA. Our own clinical pilot study showed that over 35% of those treated with CPA received the wrong dose, and therefore did not get proper treatment. TailorDose® offers a solution for this problem. A single blood sample, followed by a quick analysis enables the physician to dose CPA correctly for each patient.